Hypertension New Updates
- Targeting a Hormonal Cause of Hypertension Anand Vaidya et.al. N Engl J Med 2025;392: e14
- Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: an Italian multicenter prospective study Silvio Borrelli et.al. CKJ 2024
- Malignant Hypertension: Navigating Ambiguity of Definitions and Challenges in Management
- REVIEW Guidelines for the management of hypertension in CKD patients: where do we stand in 2024? Marieta Theodorakopoulou et.al. CKJ 2024
- Revisiting resistant hypertension: a comprehensive review. RyanJ.Chan et.al. Internal Medicine Journal 53 (2023) 1739–1751.
- Evaluation and Management of Resistant Hypertension: Core Curriculum 2024. Jennifer L. Cluett et.al. AJKD 2024.
- Resistant Hypertension in Dialysis: Epidemiology, Diagnosis, and Management. Panagiotis I. Georgianos et.al. JASN 35: 505–514, 2024.
- Revisiting Hypertension Treatment in Patients With Chronic Kidney Disease. Mario Funes Hernandez et.al. Semin Nephrol 000:151514 Ó 2024.
- Recent studies on hypertension prevalence and control in India 2023, Rajeev Gupta et.al. ; Hypertension Research 2024.
- Blood Pressure Control and the Prevention of Incident CKD: The Disconnect Between Cohort Studies and Randomized Trials, Rajiv Agarwal et.al. ; AJKD 2024.
- Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial ESPIRIT trial, Jiamin Liu et.al. Lancet 2024.
- Current perspectives and trends of the research on hypertensive nephropathy: a bibliometric analysis from 2000 to 2023 ,Lan Wang et.al. Renal Failure 2024.
- Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association, Jennifer L. Cluett et.al. Hypertension 2024.